erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the..
mayo clinic: "migraine: diagnosis & treatment," "monoclonal antibody drugs for cancer: how they work.".
lawmakers should revisit that idea when lepage is no longer in office next year.. march 2018 (23).. ..